<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UZB-T-RDC-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Reduce TB incidence and mortality in Uzbekistan by increasing quality of TB care - Uzbekistan (01-Jul-2016-30-Jun-2018)</narrative>
    </title>
    <description type="1">
      <narrative>Uzbekistan, Tuberculosis, Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </description>
    <description type="2">
      <narrative>Goals: By 2020 reduce the MDR burden by 50 % compared to 2014 levels; By 2020 reduce the TB incidence rate to 38 per 100,000 population; By 2020 reduce the TB-related death rate to 2,6 per 100,000 population. Objectives: To Improve quality of TB treatment in adults and children by securing an uninterrupted supply of internationally quality assured first and second line anti TB drugs, including the relevant pediatric formulations and IPT for children and PLHIV; To increase detection of TB and M/XDR TB by providing access for all TB patients to Xpert testing, with follow-on SL DST for all patients with R resistance; To prevent nosocomial transmission.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </participating-org>
    <other-identifier ref="UZB-T-RDCP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-07-01" />
    <activity-date type="2" iso-date="2016-07-01" />
    <activity-date type="3" iso-date="2018-06-30" />
    <activity-date type="4" iso-date="2018-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UZ" percentage="100">
      <narrative>Uzbekistan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="8b0f93b4-a8d6-4b36-8766-64b8a0a27f21">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-27" />
      <value currency="USD" value-date="2016-07-27">10676050.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a53241a5-8cd3-425b-8c6e-701404efdfa0">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-29" />
      <value currency="USD" value-date="2016-07-29">963939.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="32c820cd-9ae1-40dd-992f-b24946c75ee0">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-06" />
      <value currency="USD" value-date="2016-12-06">780400.10</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d4b7894-621e-4e84-9e03-d398a26e1c8e">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-06" />
      <value currency="USD" value-date="2016-12-06">342035.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="654ce355-0abd-4e50-8372-2d2e5c3719d3">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-06" />
      <value currency="USD" value-date="2016-12-06">1480006.74</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="948d070e-947e-4406-97b6-c582af1094fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-16" />
      <value currency="USD" value-date="2016-12-16">967613.46</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d16c8a9-01cc-4446-b4e4-8e539f0a4969">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">10266205.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c7a78181-28dd-42c2-b478-81900a40020e">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">-6142055.70</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08e6f434-c2b3-47ce-8abc-5d31a0e0bd6f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">152241.14</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2b9a3a36-27a7-4b0d-bc51-a2ae139dfe0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">48834.85</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="46a5a17f-bf55-4dec-9040-bd79b01977d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6c8a25a-1a0a-4eb2-b846-b0ee9641de23">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">596121.08</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7f596ea3-87fc-45a5-8bb9-109b0c76273f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">1934669.62</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="662902bd-dbd0-42a4-a0a0-0c3a042ab348">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-14" />
      <value currency="USD" value-date="2017-11-14">3375694.65</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3695772-3dec-4c1c-bb43-3aee3e2a79db">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-24" />
      <value currency="USD" value-date="2017-11-24">838949.21</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6ec9cfc6-80c8-47c7-bb38-1f3bf1bfb67f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-08" />
      <value currency="USD" value-date="2017-12-08">1101383.83</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6bc4b0fe-e34c-4182-bb37-64a48f0a9dfd">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-12" />
      <value currency="USD" value-date="2017-12-12">1030439.81</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c86a2d9-039e-454e-b1bc-13115be27ee6">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b09c464-524b-4d4c-a9b9-83472bd06e18">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db28ee26-0bf3-4108-8161-c2ddb473a345">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-04" />
      <value currency="USD" value-date="2018-04-04">50000.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="15621e9d-f5ee-4c48-b49c-e5860572a7d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-03" />
      <value currency="USD" value-date="2018-05-03">1117870.81</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a0d84ffd-2be2-4d9a-906c-1619b2de3fb8">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-03" />
      <value currency="USD" value-date="2018-05-03">-1167870.81</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da12d31a-d779-4a2e-a773-add99b148496">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-04" />
      <value currency="USD" value-date="2018-05-04">1014769.81</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94519de7-21e4-4fe5-827c-0580d77dfc49">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-22" />
      <value currency="USD" value-date="2018-05-22">663076.32</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e2db92dd-fbe2-48d4-ac2a-b23e0b005782">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-22" />
      <value currency="USD" value-date="2018-05-22">-103101.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da2e1cff-c3db-4d18-97cc-4512748f7a70">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-24" />
      <value currency="USD" value-date="2018-05-24">663076.32</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="881fa870-bac5-42d0-b74c-477472a38294">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9361337a-3d1a-4da1-ad97-e4693e32b680">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-01" />
      <value currency="USD" value-date="2021-06-01">71463.28</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="517dbf2d-5170-4cf4-8efb-0c866d4294f9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-29" />
      <value currency="USD" value-date="2021-06-29">-71463.28</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UZB-T-RDC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB - Other1: Percentage of previously treated TB patients receiving DST (bacteriologicallyconfirmed cases)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>MDR TB - Other1: Percentage of previously treated TB patients receiving DST (bacteriologicallyconfirmed cases)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="45">
          <comment>
            <narrative>Numerator: 741; Denominator: 1809.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 750; Denominator: 1250.</narrative>
            </comment>
          </target>
          <actual value="58.3">
            <comment>
              <narrative>Numerator: 465; Denominator: 797.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="66">
            <comment>
              <narrative>Numerator: 825; Denominator: 1250.</narrative>
            </comment>
          </target>
          <actual value="0.6">
            <comment>
              <narrative>Numerator: 504; Denominator: 815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 480; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 443; Denominator: 672.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 600; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="90.8">
            <comment>
              <narrative>Numerator: 1256; Denominator: 1383.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB-other 2: Percentage of new TB patients receiving DST (bacteriologically confirmed cases)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>MDR TB-other 2: Percentage of new TB patients receiving DST (bacteriologically confirmed cases)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="80" />
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 1648; Denominator: 1939.</narrative>
            </comment>
          </target>
          <actual value="84.4">
            <comment>
              <narrative>Numerator: 315; Denominator: 373.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="86">
            <comment>
              <narrative>Numerator: 1584; Denominator: 1842.</narrative>
            </comment>
          </target>
          <actual value="0.8">
            <comment>
              <narrative>Numerator: 481; Denominator: 572.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 1602; Denominator: 1842.</narrative>
            </comment>
          </target>
          <actual value="95.1">
            <comment>
              <narrative>Numerator: 500; Denominator: 526.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 1540; Denominator: 1750.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 625; Denominator: 625.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 4955; Denominator: 8209; Percentage: 60.4%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1520.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1520.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1387.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1450.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1291.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1450.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1515.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 3665; Denominator: 4955; Percentage: 74%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1490.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1007.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1490.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1298.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1420.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1120.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1420.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1246.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="40" />
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 2; Denominator: 5.</narrative>
            </comment>
          </target>
          <actual value="40">
            <comment>
              <narrative>Numerator: 2; Denominator: 5.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 3; Denominator: 5.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 4; Denominator: 6.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 4; Denominator: 5.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 4; Denominator: 6.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5; Denominator: 5.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 6; Denominator: 6.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17.4" />
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="10" />
          <actual value="5.2">
            <comment>
              <narrative>Numerator: 56; Denominator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="9" />
          <actual value="0">
            <comment>
              <narrative>Numerator: 47; Denominator: 1111.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="8" />
          <actual value="5.4">
            <comment>
              <narrative>Numerator: 55; Denominator: 1015.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="7" />
          <actual value="2.8">
            <comment>
              <narrative>Numerator: 36; Denominator: 1298.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 3961; Denominator: 543322; Percentage: 0.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1875.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1875.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2373.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1780.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1780.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2392.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 20812; Denominator: 23300; Percentage: 89.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 18852; Denominator: 20812; Percentage: 90.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1960; Denominator: 20812; Percentage: 9.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8126; Denominator: 20812; Percentage: 39.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 12686; Denominator: 20812; Percentage: 60.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 19715; Denominator: 20812; Percentage: 94.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1097; Denominator: 20812; Percentage: 5.27%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8697.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8697.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10234; Percentage: 1.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8435.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8746.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7802; Denominator: 8746; Percentage: 89.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 944; Denominator: 8746; Percentage: 10.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3662; Denominator: 8746; Percentage: 41.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5084; Denominator: 8746; Percentage: 58.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8346; Denominator: 8746; Percentage: 95.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 400; Denominator: 8746; Percentage: 4.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8436.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9941.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 7928; Denominator: 20812; Percentage: 38.1%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3918.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2940.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3917.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4008; Percentage: 1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4220.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3492.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4220.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3826.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="69">
          <comment>
            <narrative>Numerator: 3370; Denominator: 4878.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="75.3">
            <comment>
              <narrative>Numerator: 2950; Denominator: 3918.</narrative>
            </comment>
          </target>
          <actual value="83.8">
            <comment>
              <narrative>Numerator: 1503; Denominator: 1794.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="76.6">
            <comment>
              <narrative>Numerator: 3000; Denominator: 3917.</narrative>
            </comment>
          </target>
          <actual value="0.8">
            <comment>
              <narrative>Numerator: 1981; Denominator: 2369.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="77.6">
            <comment>
              <narrative>Numerator: 3275; Denominator: 4220.</narrative>
            </comment>
          </target>
          <actual value="81.9">
            <comment>
              <narrative>Numerator: 1499; Denominator: 1831.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="78.8">
            <comment>
              <narrative>Numerator: 3325; Denominator: 4220.</narrative>
            </comment>
          </target>
          <actual value="84">
            <comment>
              <narrative>Numerator: 2090; Denominator: 2488.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="90.1">
          <comment>
            <narrative>Numerator: 274; Denominator: 304.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="95.9">
            <comment>
              <narrative>Numerator: 140; Denominator: 146.</narrative>
            </comment>
          </target>
          <actual value="79.6">
            <comment>
              <narrative>Numerator: 203; Denominator: 255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="95.9">
            <comment>
              <narrative>Numerator: 140; Denominator: 146.</narrative>
            </comment>
          </target>
          <actual value="0.8">
            <comment>
              <narrative>Numerator: 214; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="96.6">
            <comment>
              <narrative>Numerator: 141; Denominator: 146.</narrative>
            </comment>
          </target>
          <actual value="83">
            <comment>
              <narrative>Numerator: 215; Denominator: 259.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="96.6">
            <comment>
              <narrative>Numerator: 141; Denominator: 146.</narrative>
            </comment>
          </target>
          <actual value="96.5">
            <comment>
              <narrative>Numerator: 250; Denominator: 259.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - public sector</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - public sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="2.9">
          <comment>
            <narrative>Numerator: 720; Denominator: 25168.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="5.2">
            <comment>
              <narrative>Numerator: 450; Denominator: 8697.</narrative>
            </comment>
          </target>
          <actual value="1.8">
            <comment>
              <narrative>Numerator: 152; Denominator: 8267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="5.2">
            <comment>
              <narrative>Numerator: 450; Denominator: 8697.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 209; Denominator: 10234.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="5.3">
            <comment>
              <narrative>Numerator: 450; Denominator: 8435.</narrative>
            </comment>
          </target>
          <actual value="3.3">
            <comment>
              <narrative>Numerator: 286; Denominator: 8748.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="5.3">
            <comment>
              <narrative>Numerator: 450; Denominator: 8436.</narrative>
            </comment>
          </target>
          <actual value="2.5">
            <comment>
              <narrative>Numerator: 273; Denominator: 10805.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="86">
          <comment>
            <narrative>Numerator: 172; Denominator: 200.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 180; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 196; Denominator: 196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 186; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 176; Denominator: 196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 192; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 196; Denominator: 196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 200; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 198; Denominator: 198.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 17843; Denominator: 21571; Percentage: 82.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 13730; Denominator: 15714; Percentage: 87.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1984; Denominator: 15714; Percentage: 12.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 6486; Denominator: 15714; Percentage: 41.28%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9228; Denominator: 15714; Percentage: 58.72%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 15301; Denominator: 15714; Percentage: 97.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 413; Denominator: 15714; Percentage: 2.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5230; Denominator: 5971; Percentage: 87.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6580; Denominator: 7412; Percentage: 88.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5280; Denominator: 5971; Percentage: 88.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7922; Denominator: 8942; Percentage: 0.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5185; Denominator: 5791; Percentage: 89.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6544; Denominator: 7423; Percentage: 88.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5483; Denominator: 6544; Percentage: 83.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1061; Denominator: 6544; Percentage: 16.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2932; Denominator: 6544; Percentage: 44.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3612; Denominator: 6544; Percentage: 55.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 6410; Denominator: 6544; Percentage: 98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 0; Denominator: 6544.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 134; Denominator: 6544; Percentage: 2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5230; Denominator: 5792; Percentage: 90.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7905; Denominator: 8964; Percentage: 88.2%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="37.9">
          <comment>
            <narrative>Numerator: 12121; Denominator: 32000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="40.6">
            <comment>
              <narrative>Numerator: 6500; Denominator: 16000.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 758; Denominator: 863.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="40.6">
            <comment>
              <narrative>Numerator: 6500; Denominator: 16000.</narrative>
            </comment>
          </target>
          <actual value="0.5">
            <comment>
              <narrative>Numerator: 8201; Denominator: 16402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="42.4">
            <comment>
              <narrative>Numerator: 7000; Denominator: 16500.</narrative>
            </comment>
          </target>
          <actual value="77.9">
            <comment>
              <narrative>Numerator: 12771; Denominator: 16402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="42.4">
            <comment>
              <narrative>Numerator: 7000; Denominator: 16500.</narrative>
            </comment>
          </target>
          <actual value="68.1">
            <comment>
              <narrative>Numerator: 12065; Denominator: 17708.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="45.4">
          <comment>
            <narrative>Numerator: 354; Denominator: 780.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 300; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="72.7">
            <comment>
              <narrative>Numerator: 11295; Denominator: 15544.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="53.3">
            <comment>
              <narrative>Numerator: 320; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="0.6">
            <comment>
              <narrative>Numerator: 269; Denominator: 472.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="55.4">
            <comment>
              <narrative>Numerator: 360; Denominator: 650.</narrative>
            </comment>
          </target>
          <actual value="63.2">
            <comment>
              <narrative>Numerator: 253; Denominator: 400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 390; Denominator: 650.</narrative>
            </comment>
          </target>
          <actual value="71">
            <comment>
              <narrative>Numerator: 311; Denominator: 438.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 22347; Denominator: 22804; Percentage: 98%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8523; Denominator: 8697; Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 20006; Denominator: 20006; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8523; Denominator: 8697; Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11135; Denominator: 11135.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8267; Denominator: 8436; Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9447; Denominator: 9447; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8267; Denominator: 8435; Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10797; Denominator: 10805; Percentage: 99.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UZB-T-RDC-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Program continuation of  reduce TB incidence and mortality in Uzbekistan by increasing quality of TB care - Uzbekistan (01-Jul-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Uzbekistan, Tuberculosis, Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To improve TB diagnosis, treatment and care while strengthening TB control service, shifting to outpatient care, optimizing hospital infrastructure, developing human resources and improving infection control. Objectives: To increase detection of TB and DR TB by providing access for all TB patients to quality assured laboratory diagnostics; To improve quality of TB and DR TB treatment in adults and children by securing an uninterrupted supply of quality assured anti TB drugs and necessary quality assured treatment monitoring.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
    </participating-org>
    <other-identifier ref="UZB-T-RDCP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-07-01" />
    <activity-date type="2" iso-date="2018-07-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UZ" percentage="100">
      <narrative>Uzbekistan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="95.37">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="4.63">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="4.05">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="0.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="7.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="2.97">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="72.41">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="8.39">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="3.83">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">3281301.36</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">11290424.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">6546531.28</value>
    </budget>
    <capital-spend percentage="9.81" />
    <transaction ref="18502585-366c-44c8-8234-cfa6b8d5f772">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-22" />
      <value currency="USD" value-date="2018-10-22">9525914.62</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6903812-fc5d-4cf8-b11f-d256d93432c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-25" />
      <value currency="USD" value-date="2018-10-25">747818.70</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dddca710-ab48-49cb-812c-4bc74ccccb74">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-11" />
      <value currency="USD" value-date="2018-12-11">1728825.43</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="89a9c852-5175-4926-a88b-05affa6b10dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">1088998.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f069a069-2b5e-49e7-8d6f-082f5e4f1bdd">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-28" />
      <value currency="USD" value-date="2019-02-28">809482.62</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e49bd551-aae5-47ba-a56f-93c80a0c4b3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-12" />
      <value currency="USD" value-date="2019-04-12">228653.40</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1d2b80ac-a82a-42cf-9506-9aeca8202b39">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-04-26" />
      <value currency="USD" value-date="2019-04-26">4872136.47</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04188bdc-0c1d-4fa4-8f1e-9a18136f06fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-04-26" />
      <value currency="USD" value-date="2019-04-26">-4922136.47</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="af04dc90-120d-41b7-98db-eee584b28e9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-01" />
      <value currency="USD" value-date="2019-05-01">4240270.60</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="98b17fec-b618-4156-9e5f-ce0f1cc22f2e">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d415fde-2d57-4250-8d6e-cae4f7dbb6bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c42232f2-5904-4ee7-835e-dc5f89cc4eee">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-10" />
      <value currency="USD" value-date="2019-12-10">6407727.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1f5d92e4-cf17-4f78-8a18-4f5759321a94">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-10" />
      <value currency="USD" value-date="2019-12-10">-631865.87</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e8d33181-014c-4848-a9c3-f974564ea9d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-12" />
      <value currency="USD" value-date="2019-12-12">587620.15</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ca7267e5-1cda-4c8a-a056-8f8d43c13659">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-12" />
      <value currency="USD" value-date="2019-12-12">4926187.55</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3c88f1c8-379e-4cad-b769-3e0debb67bb0">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-07" />
      <value currency="USD" value-date="2020-02-07">564782.54</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c5d05a07-8eed-47cf-ab53-4a51c4ece7c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5905e5b-be27-4f1a-9721-ee423032b86a">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-25" />
      <value currency="USD" value-date="2020-06-25">6013753.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c309825e-c2cc-476f-8a4f-78ed77b36309">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-25" />
      <value currency="USD" value-date="2020-06-25">-329136.76</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9869d705-ef6a-4aab-94f0-146a4e0ef156">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">3836341.72</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="36b93e22-aff3-4ea1-aabf-d395e35f8c9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-28" />
      <value currency="USD" value-date="2020-10-28">632112.39</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a5869150-8ef8-40eb-8d27-0dda6f05c38a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec391201-bd23-44e7-9379-0cb39d90c332">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-02" />
      <value currency="USD" value-date="2020-12-02">560144.90</value>
      <description>
        <narrative>Global Fund disbursement to UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ad0fe7fd-b04c-49f9-ae0f-b7e3331c36db">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">-985153.99</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="36bd1e9c-a1aa-469f-b49c-b8a9785732a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">0.00</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66f92c70-51a1-42e7-8b0b-5f0695b4a738">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-12-29" />
      <value currency="USD" value-date="2020-12-29">534101.26</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ff56c13-9abf-46a6-a59c-bafa8c80c1af">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-07" />
      <value currency="USD" value-date="2021-01-07">-534101.26</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c520bb0-4c16-40b4-a2ac-6ce0a4ec47fd">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-01" />
      <value currency="USD" value-date="2021-06-01">121985.81</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e126e663-4d1d-438a-ba0f-46280f0bd8e8">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-01" />
      <value currency="USD" value-date="2021-06-01">226695.40</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9b5dfd2a-411d-4f89-b216-a1f661132564">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-09" />
      <value currency="USD" value-date="2021-06-09">-121985.81</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eb045fa4-8443-42bc-9195-a02ddb1a0fa9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-11" />
      <value currency="USD" value-date="2021-06-11">-226695.40</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b3856da-6ef2-4a66-b0dc-7549b33fecc5">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-24" />
      <value currency="USD" value-date="2021-06-24">164275.81</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9064a7b-c3a4-4e46-af14-5c70f23629af">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">-164275.81</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="32d0e87b-a3aa-4089-a368-f6ec63148590">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">4642.19</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c774262-cd91-4193-b986-5a7c5325ab8a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">-4642.19</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40dfbff6-9ae2-443a-b7da-1f14437c4a23">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">30689.77</value>
      <description>
        <narrative>Funds returned to the Global Fund from UZB-T-RDCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e11656f4-d9d4-4b43-a9bd-437930f97e71">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-20" />
      <value currency="USD" value-date="2021-12-20">-30689.77</value>
      <description>
        <narrative>Global Fund commitment to UZB-T-RDCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="UZB-T-RDCP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">590202.30</value>
      <description>
        <narrative>Expenditure reported by Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan for UZB-T-RDCP02, Jul 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UZB-T-RDCP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">6481967.00</value>
      <description>
        <narrative>Expenditure reported by Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan for UZB-T-RDCP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UZB-T-RDCP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">7612093.66</value>
      <description>
        <narrative>Expenditure reported by Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan for UZB-T-RDCP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UZB-T-RDCP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">5007067.78</value>
      <description>
        <narrative>Expenditure reported by Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan for UZB-T-RDCP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican DOTS Centre  Ministry of Health of the Republic of Uzbekistan</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UZB-T-RDC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 3443.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1274; Denominator: 1280; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1274; Denominator: 1280; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1274; Denominator: 1280; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1274; Denominator: 1280; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1274; Denominator: 1280; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6; Denominator: 1280; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6; Denominator: 1280; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6; Denominator: 1280; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6; Denominator: 1280; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6; Denominator: 1280; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 527; Denominator: 1280; Percentage: 41.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 527; Denominator: 1280; Percentage: 41.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 527; Denominator: 1280; Percentage: 41.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 527; Denominator: 1280; Percentage: 41.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 527; Denominator: 1280; Percentage: 41.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 753; Denominator: 1280; Percentage: 58.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 753; Denominator: 1280; Percentage: 58.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 753; Denominator: 1280; Percentage: 58.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 753; Denominator: 1280; Percentage: 58.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 753; Denominator: 1280; Percentage: 58.83%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3100.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2613.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2585; Denominator: 2613; Percentage: 98.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 28; Denominator: 2613; Percentage: 1.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 956; Denominator: 2613; Percentage: 36.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1657; Denominator: 2613; Percentage: 63.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1450.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1302.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1272; Denominator: 1302; Percentage: 97.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 30; Denominator: 1302; Percentage: 2.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 442; Denominator: 1302; Percentage: 33.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 860; Denominator: 1302; Percentage: 66.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2900.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3535.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2788.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1169.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1145.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 434.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 735.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2068.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1988.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 80.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 804.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1264.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="257" />
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="350" />
          <actual value="432" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="225" />
          <actual value="395" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="450" />
          <actual value="688" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="350" />
          <actual value="253" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="700" />
          <actual value="425" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 2127.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2106; Denominator: 2127; Percentage: 99.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2106; Denominator: 2127; Percentage: 99.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2106; Denominator: 2127; Percentage: 99.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2106; Denominator: 2127; Percentage: 99.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2106; Denominator: 2127; Percentage: 99.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 2127; Percentage: 0.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 2127; Percentage: 0.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 2127; Percentage: 0.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 2127; Percentage: 0.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 2127; Percentage: 0.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 769; Denominator: 2127; Percentage: 36.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 769; Denominator: 2127; Percentage: 36.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 769; Denominator: 2127; Percentage: 36.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 769; Denominator: 2127; Percentage: 36.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 769; Denominator: 2127; Percentage: 36.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1358; Denominator: 2127; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1358; Denominator: 2127; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1358; Denominator: 2127; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1358; Denominator: 2127; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1358; Denominator: 2127; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 142; Denominator: 2127; Percentage: 6.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 142; Denominator: 2127; Percentage: 6.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 142; Denominator: 2127; Percentage: 6.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 142; Denominator: 2127; Percentage: 6.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 142; Denominator: 2127; Percentage: 6.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 128.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 128.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 128.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 128.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 128.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2750.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2330.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2293; Denominator: 2330; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 37; Denominator: 2330; Percentage: 1.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 832; Denominator: 2330; Percentage: 35.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1498; Denominator: 2330; Percentage: 64.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 305; Denominator: 2330; Percentage: 13.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 186; Denominator: 2330; Percentage: 8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1225.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1196; Denominator: 1225; Percentage: 97.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 29; Denominator: 1225; Percentage: 2.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 419; Denominator: 1225; Percentage: 34.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 806; Denominator: 1225; Percentage: 65.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 215; Denominator: 1225; Percentage: 17.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 171; Denominator: 1225; Percentage: 14%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2267.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2189.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 78.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 835.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1432.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 426.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 307.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1325.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 874.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 838.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 36.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 329.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 545.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 94.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 94.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2650.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1536.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1471.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 65.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 608.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 928.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 230.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="84.89">
          <comment>
            <narrative>Numerator: 5602; Denominator: 6599.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90" />
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 3549; Denominator: 3636.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="95" />
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 4515; Denominator: 4566.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="95" />
          <actual value="99.9">
            <comment>
              <narrative>Numerator: 3780; Denominator: 3783.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100" />
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 3557; Denominator: 3589.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100" />
          <actual value="99">
            <comment>
              <narrative>Numerator: 2512; Denominator: 2537.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="5.22">
          <comment>
            <narrative>Numerator: 56; Denominator: 1072.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="4.5" />
          <actual value="2.7" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="4.2" />
          <actual value="2.1">
            <comment>
              <narrative>Numerator: 26; Denominator: 1246.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="4.2" />
          <actual value="1.4">
            <comment>
              <narrative>Numerator: 15; Denominator: 1084.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="2" />
          <actual value="3.1">
            <comment>
              <narrative>Numerator: 38; Denominator: 1225.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="2" />
          <actual value="2">
            <comment>
              <narrative>Numerator: 21; Denominator: 1048.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 16050.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7253; Denominator: 8267; Percentage: 87.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7253; Denominator: 8267; Percentage: 87.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7253; Denominator: 8267; Percentage: 87.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7253; Denominator: 8267; Percentage: 87.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7253; Denominator: 8267; Percentage: 87.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 8267; Percentage: 12.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 8267; Percentage: 12.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 8267; Percentage: 12.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 8267; Percentage: 12.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 8267; Percentage: 12.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2940; Denominator: 8267; Percentage: 35.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2940; Denominator: 8267; Percentage: 35.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2940; Denominator: 8267; Percentage: 35.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2940; Denominator: 8267; Percentage: 35.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2940; Denominator: 8267; Percentage: 35.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3550; Denominator: 8267; Percentage: 42.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3550; Denominator: 8267; Percentage: 42.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3550; Denominator: 8267; Percentage: 42.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3550; Denominator: 8267; Percentage: 42.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3550; Denominator: 8267; Percentage: 42.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4717; Denominator: 8267; Percentage: 57.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4717; Denominator: 8267; Percentage: 57.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4717; Denominator: 8267; Percentage: 57.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4717; Denominator: 8267; Percentage: 57.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4717; Denominator: 8267; Percentage: 57.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 7819; Denominator: 8267; Percentage: 94.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 7819; Denominator: 8267; Percentage: 94.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 7819; Denominator: 8267; Percentage: 94.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 7819; Denominator: 8267; Percentage: 94.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 7819; Denominator: 8267; Percentage: 94.58%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 8267; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 8267; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 8267; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 8267; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 0; Denominator: 8267; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 448; Denominator: 8267; Percentage: 5.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 448; Denominator: 8267; Percentage: 5.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 448; Denominator: 8267; Percentage: 5.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 448; Denominator: 8267; Percentage: 5.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 448; Denominator: 8267; Percentage: 5.42%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18072.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 15983; Denominator: 18072; Percentage: 88.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2089; Denominator: 18072; Percentage: 11.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 7216; Denominator: 18072; Percentage: 39.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7883; Denominator: 18072; Percentage: 43.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10189; Denominator: 18072; Percentage: 56.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 17425; Denominator: 18072; Percentage: 96.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 11; Denominator: 18072; Percentage: 0.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 636; Denominator: 18072; Percentage: 3.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8900.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9873.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 8699; Denominator: 9873; Percentage: 88.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1174; Denominator: 9873; Percentage: 11.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 4335; Denominator: 9873; Percentage: 43.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4245; Denominator: 9873; Percentage: 43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5628; Denominator: 9873; Percentage: 57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 9503; Denominator: 9873; Percentage: 96.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 13; Denominator: 9873; Percentage: 0.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 357; Denominator: 9873; Percentage: 3.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17800.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18080.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 15795.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2285.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 7858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7979.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10101.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 17431.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 633.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8800.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7714.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6735.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 979.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 3336.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3412.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4302.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 7449.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13182.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 11403.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1779.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 5659.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5953.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 7229.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 12686.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 437.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 15084; Denominator: 16981; Percentage: 88.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2042; Denominator: 15084; Percentage: 13.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2042; Denominator: 15084; Percentage: 13.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2042; Denominator: 15084; Percentage: 13.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2042; Denominator: 15084; Percentage: 13.54%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 89.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13792; Denominator: 15464; Percentage: 89.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 6412; Denominator: 14751; Percentage: 43.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7385; Denominator: 8201; Percentage: 90%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3554; Denominator: 7877; Percentage: 45.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13267; Denominator: 14705; Percentage: 90.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7143; Denominator: 7861; Percentage: 90.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3534; Denominator: 7792; Percentage: 45.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 90.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13031; Denominator: 14413; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 6579.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="87.83">
          <comment>
            <narrative>Numerator: 758; Denominator: 863.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="89" />
          <actual value="81">
            <comment>
              <narrative>Numerator: 247; Denominator: 305.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90" />
          <actual value="86.3">
            <comment>
              <narrative>Numerator: 308; Denominator: 357.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="81.1">
            <comment>
              <narrative>Numerator: 227; Denominator: 280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="91" />
          <actual value="85.1">
            <comment>
              <narrative>Numerator: 229; Denominator: 269.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="91" />
          <actual value="84.6">
            <comment>
              <narrative>Numerator: 143; Denominator: 169.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="72.66">
          <comment>
            <narrative>Numerator: 11295; Denominator: 15544.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="75" />
          <actual value="73.9">
            <comment>
              <narrative>Numerator: 27940; Denominator: 37813.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="77" />
          <actual value="93">
            <comment>
              <narrative>Numerator: 19375; Denominator: 20836.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="77" />
          <actual value="70.5">
            <comment>
              <narrative>Numerator: 29910; Denominator: 42425.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="79" />
          <actual value="62.4">
            <comment>
              <narrative>Numerator: 12835; Denominator: 20570.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="79" />
          <actual value="64">
            <comment>
              <narrative>Numerator: 26699; Denominator: 41704.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>